Follow Us GraphicFacebook IconTwitter IconLinkedIn Icon
Search Graphic

Expert Financial Analysis and Reporting

Portola Announces a Delay in PDUFA Date for AndexXa (PTLA, Buy, $54.86)

Portola announced after the close on December 22, 2017 that the FDA will extend its review of AndexXa (andexanet alfa)…
Read more…